Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV002291696 | SCV002584337 | likely pathogenic | not provided | 2023-05-25 | criteria provided, single submitter | clinical testing | Reported with c.29963-1G>C on the opposite allele (in trans) in a patient with congenital myopathy in the published literature; the c.92812dup variant was paternally inherited but clinical information on the father was not provided (Jang et al., 2019); Not observed at significant frequency in large population cohorts (gnomAD); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Located in the A-band region of TTN in which the majority of loss of function variants have been associated with autosomal dominant titinopathies (Herman et al., 2012); This variant is associated with the following publications: (PMID: 22335739, 31332964) |
Department of Rehabilitation Medicine, |
RCV000757916 | SCV000882767 | pathogenic | Early-onset myopathy with fatal cardiomyopathy; Congenital titinopathy | 2019-02-11 | no assertion criteria provided | research | The proband has another variant, NG_011618.3: c.26231-1G>C. |